Commentary to the guideline for diagnosis and treatment of syncopes - The European Society of Cardiology 2001 and the 2004 update;Kommentar zu den leitlinien zur diagnostik und therapie von synkopen - Der europäischen gesellschaft für kardiologie 2001 und dem update 2004

Zeitschrift fur Kardiologie

Volumn 94, Issue 9, 2005, Pages 592-612

  Seidl, K ^a   Schuchert, A ^b   Tebbenjohanns, J ^c   Hartung, W ^d  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Stadtisches Krankenhaus Hildesheim   (Germany)

^d Herzzentrum Hannover Kirchrode   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; ATRIOVENTRICULAR BLOCK; CARDIOLOGY; CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEMODYNAMIC MONITORING; HUMAN; NOTE; ORTHOSTATIC HYPOTENSION; SYNCOPE; TACHYCARDIA; TREATMENT INDICATION;

CARDIOLOGY; EUROPE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SOCIETIES, MEDICAL; SYNCOPE;

EID: 24644463274     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0230-5     Document Type: Note

References (128)

1. Lempert T, Bauer M, Schmidt D (1994) Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 36:233-237
2. The Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope-update (2004) Executive Summary. Eur Heart J 25(22)2054-2072
3. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Block Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W (Task Force on Syncope) (2001) Guidelines on management (diagnosis and treatment) of syncope. Eur Heart Journal 22:1256-1306
4. Trappe H-J (2003) Leitlinien der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung. Z Kardiol 92:689-693
5. Silverstein MD, Singer DE, Mulley A et al (1982) Patients with syncope admitted to medical intensive care units. JAMA 248:1185-1189
6. Kapoor WN (1990) Evaluation and outcome of patients with syncope. Medicine 69:169-175
7. Kapoor WN, Hanusa B (1996) Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med 100:646-655
8. Martin TP, Hanusa BH, Kapoor WN (1997) Risk stratification of patients with syncope. Ann Emerg Med 29:459-466
9. Alboni P, Brignole M, Menozzi C et al (2001) The diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol 37:1921-1928
10. Middlekauff H, Stevenson W, Stevenson L, Saxon L (1993) Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 21:110-116
11. Calkins H, Shyr Y, Frumin H, Schork A, Morady F (1995) The value of clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block and neurocardiogenic syncope. Am J Med 98:365-373
12. Sheldon R, Rose S, Fisher M, Rucker D, Connolly SJ, Ritchie D, Koshman ML, Frenneuaux M (2001) Historical criteria for the causes of syncope in patients with structural heart disease. PACE 24:354
13. Bloomfield DM, Sheldon R, Grubb BP, Calkins H, Sutton R (1999) Panel consensus. Putting it together: A new treatment algorithm for vasovagal syncope and related disorders. Am J Cardiol 84:33Q-39Q
14. Tonkin AL, Frewin DB (1999) Drugs, toxins and chemicals that alter autonomic function. In: Mathias CJ, Bannister R, (eds) Autonomic failure, 4th edn. Oxford University Press, Oxford, pp 527-533
15. Mathias CJ, Polinsky RJ (1999) Separating the primary autonomic failure syndroms, mulitple system atrophy, and pure autonomic failure from Parkinson's disease. In: Stern GM, ed. Parkinson's disease: Advances in Neurology, vol 80. Lippincott, Philadelphia
16. Markush RE, Karp HR, Heyman A, O'Fallon WM (1975) Epidemiologic study of migraine symptoms in young women. Neurol 25:430-435
17. McHarg ML, Shinnar S, Rascoff H, Walsh CA (1997) Syncope in childhood. Pediatr Cardiol 18:376-371
18. Van Donselaar CA, Geerts AT, Schimsheimer RJ (1990) Usefulness of an aura for classification of a first generalised seizure. Epilepsia 31:529-535
19. Gosselin C, Walker PM (1996) Subclavian steal syndrome. Existence clinical features, diagnosis, management. Seminars in Vasc Surg 9:93-97
20. Linzer M, Felder A, Hackel A, Perry AJ, Varia I, Melville ML (1990) Psychiatric syncope: a new look at an old disease. Psychosomatics 31:181-188
21. Kapoor W, Fortunato M, Hanusa BH, Schulberg HC (1995) Psychiatric illnesses in patients with syncope. Am J Med 99:505-512
22. Grubb BP, Gerard G, Wolfe DA, Samoil D, Davenport CW, Homan RW (1992) Syncope and seizure of psychogenic origin: identification with head-upright tilt table testing. Clin Cardiol 15:839-842
23. Konig D, Linzer M, Pontinen M, Divine GW (1992) Syncope in young adults: evidence for a combined medical and psychiatric approach. J Intern Med 232:169-176
24. Blanc JJ, L'heveder G, Mansourati J, Tea SH, Guillo Ph, Mabin D (1997) Assessment of newly recognized association: carotid sinus hypersensitivity and denervation of sternocleidomastoid muscles. Circulation 95:2548-2551
25. O'Mahoney D (1995) Pathophysiology of carotid sinus hypersensitivity in elderly patients. Lancet 346:950-952
26. Tea SH, Mansourati J, L'Heveder G, Mabin D, Blanc JJ (1996) New insights into the pathophysiology of carotid sinus syndrome. Circulation 93:1411-1416
27. McIntosch SJ, Lawson J, Kenny RA (1993) Clinical characteristics of vasodepressor, cardioinhibitory and mixted carotid sinus syndrome in the elderly. Am J Med 95:203-208
28. Volkmann H, Schnerch B, Kuhnert H (1990) Diagnostic value of carotid sinus hypersensitivity. PACE 13:2065-2070
29. Brignole M, Gigli G, Altomonte F et al (1985) The cardioinhibitory reflex evoked by carotid sinus stimulation in normal and in patients with cardiovascular disorders. G Ital Cardiol 15:514-519
30. Brignole M, Menozzi C, Lolli G, Bottoni N, Gaggioli G (1992) Long-term outcome of paced and non paced patients with severe carotid sinus syndrome. Am J Cardiol 69:1039-1043
31. Brignole M, Menozzi C (1992) Carotid sinus syndrome: diagnosis natural history and treatment. Eur J Cardiac Pacing Electrophysiol 4:247-254
32. Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A (1991) Carotid sinus massage, eyeball compression and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J 122:1644-1651
33. Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A (1991) Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 68:1032-1036
34. Munro N, McIntosch S, Lawson J, Morley CA, Sutton R, Kenny RA (1991) The incidence of complications after carotid sinus massage in recurrent syncope. J Clin Epidemiol 44:1037-1043
35. Richardson DA, Bexton R, Shaw FE, Steen N, Bond J, Kenny RA (2000) Complications of carotis sinus massage - a prospective series of older patients. Age and Aging 29:413-417
36. Recchia D, Barzilai B (1995) Echocardiography in the evaluation of patients with syncope. J Gen Intern Med 10:649-655
37. Panther R, Mahmood S, Gal R (1998) Echocardiography in the diagnostic evaluation of syncope. J Am Soc Echokardiogr 11:294-298
38. Krumholz HM, Douglas PS, Goldman L, Waksmonski C (1994) Clinical utility of transthoracic two-dimensional and Doppler echocardiography. J Am Coll Cardiol 24:125-131
39. Kapoor WN (1992) Evaluation and management of the patient with syncope. JAMA 268:2553-2560
40. Bass EB, Curtiss EJ, Arena VC et al (1990) The duration of Holter monitoring in patients with syncope: is 24 hours enough? Arch Intern Med 150:1073-1078
41. Linzer M, Pritchett ELC, Pontinen M, McCarthy E, Divine GW (1990) Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol 66:214-219
42. Krahn AD, Klein GJ, Yee R, Norris C (1998) Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol 82:117-119
43. Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C (1999) Use of an extended monitoring strategy in patients with problematic syncopes. Reveal Investigators. Circulation 26:99:406-410
44. Seidl K, Rameken M, Breunung S, Senges J, Jung W, Andresen D, van Toor A, Krahn AD, Klein GJ on behalf of the Reveal-Investigators (2000) Diagnostic assessment of recurrent unexplained syncope with a new subcutaneously implantable loop recorder. Europace 2:256-262
45. Krahn AD, Klein GJ, Fitzpatrick A, Seidl K, Zaidi A, Skanes A, Yee R (2002) The Role of empiric Pacing in unexplained syncope: Predicting the outcome of patients undergoing prolonged monitoring. PACE 25:37-41
46. Van Lieshout JJ, Wieling W, Karemaker JM, Eckberg D (1991) The vasovagal response. Clin Sci 81:575-586
47. Rea RF, Thames MD (1993) Neural control mechanisms and vasovagal syncope. J Cardiovasc Elektrophysiol 4:587-595
48. Robertson RM, Medina E, Shah N, Furlan R, Mosqueda-Garcia R (1999) Neurally mediated syncope: pathophysiology and implications for treatment. Am J Med Sci 317:102-109
49. Schondorf R, Wieling W (2000) Vasoconstrictor reserve in neurally mediated syncope. Clin Autonom Res 10:53-56
50. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P (1992) Proposed classification for tilt induced vasovagal sincope. Eur J Cardiac Pacing Elektrophysiol 3:180-218
51. Brignole M, Menozzi C, Del Rosso A et al (2000) New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Europace 2:66-76
52. Wieling W, van Lieshout JJ, ten Harkel ADJ (1998) Dynamics of circulatory adjustments to head up tilt and tilt back in healthy and sympathetically denervated subjects. Clin Sci 94:347-352
53. Fitzpatrick AP, theodorakis, G, Vardas P, Sutton R (1991) Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 17:125-130
54. Waxman MB, Yao L, Cameron DA, Wald RW, Roseman J (1989) Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol 63:58-65
55. Kapoor WN, Brant N (1992) Evaluation of syncope by upright tilt testing with isoproterenol. A non-specific test. Ann Intern Med 116:358-363
56. Morillo CA, Klein GJ, Zandri S, Yee R (1995) Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 129:901-906
57. Natale A, Aktar M, Jazayeri M et al (1995) Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 92:54-58
58. Raviele A, Gasparini G, Di Pede F et al (1994) Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J 127:103-111
59. Raviele SA, Menozzi C, Brignole M et al (1995) Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 76: 267-272
60. Oraii S, Maleki M, Minooii M, Kafai I (1999) Comparing two different protocols for tilt table testing: sublingual glyceryl trinitrate versus isoprenaline infusions. Heart 81:603-605
61. Raviele A, Giada F, Brignole M et al (2000) Diagnostic accuracy sublingual nitrogylcerin test and low-dose isoproterenol test in patients with unexplained syncope. A comparative study. Am J Cardiol 85:1194-1198
62. Bartoletti A, Gaggioli G, Bottoni N et al (1999) Head-up tilt testing potentiated with oral nitroglycerin. A randomized trial of the contribution of a drug-free phase and a nitroglycerin phase in the diagnosis of neurally mediated syncope. Europace 1:183-186
63. Del Rosso A, Bartoli P, Bartoletti A et al (1998) Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J 135:564-570
64. Natale A, Sra J, Akhtar M et al (1998) Use of sublingual nitroglycerin in patients with unexplained syncope. Am Heart J 135:564-570
65. Del Rosso A, Bartoletti A, Bartoli P et al (2000) Methodology of head-up tilt testing potentiated with sublingual nitroglycerin in unexplained syncope. Am J Cardiol 85:1007-1011
66. Foglia Manzillo G, Giada F, Beretta S, Corrado G, Sanatarone M, Raviere A (1999) Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am J Cardiol 84:284-288
67. Zeng C, Zhu Z, Hu W, Liu G, Zhu S, Zhou Y, Shi W (1999) Value of sublingual isosorbide dinitrate before isoproterenol tilt test for diagnosis of neurally mediated syncope. Am J Cardiol 83:1059-1063
68. Ammirati F, Colivicchi F, Biffi A, Magris B, Pandozi C, Santini M (1998) Head-Up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: A simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J 135:671-676
69. Voice RA, Lurie KG, Sakaguchi S, Rector TS, Benditt DG (1998) Comparison of tilt angles and provocative agents (edrophonium and isoproterenol) to improve head-upright tilt-table testing. Am J Cardiol 81:346-351
70. Fitzpatrick AP, Lee RJ, Epstein LM, Lesh MD, Eisenberg S, Sheinman MM (1996) Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation. Heart 76:406-411
71. Benditt DG, Ferguson DW, Grubb BP et al (1996) Tilt table testing for assessing syncope. ACC expert consensus document. J Am Coll Cardiol 28:263-275
72. Block M, Borggrefe M, Goedel-Meinen L, Hohnloser SH, Kalusche D, Kuck KH, Meinertz T, Oeff M, Pitschner J, Volkmann HJ (1998) Richtlinien für die Durchführung invasiver elektrophysiologischer Untersuchungen. Z Kardiol 87:502-512
73. Bergfeld L, Rosenqvist M, Vallin H, Nordlander R, Ström H (1995) Screening for sinus node dysfunction by analysis of short-term sinus cycle variations on the surface electrocardiogram. Am Heart J 130:141-147
74. Freedman RA (1999) Sinus node dysfunction. Cardiac Elektrophysiol Rev 3:74-79
75. Menozzi C, Brignole M, Alboni P et al (1998) The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavourable outcome. Am J Cardiol 82:1205-1209
76. Scheinman MM, Peters RW, Suavé MJ et al (1982) Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 50:1316-1322
77. Bergfeldt L, Edvardsson N, Rosenqvist M, Vallin H, Edhag O (1994) Atrioventricular block progression in patients with bifascicular block assessed by repeated elektrocardiography and a bradycardia-detecting pacemaker. Am J Cardiol 74:1129-1132
78. Petrac D, Radic B, Birtic K, Gjurovic J (1996) Prospective evaluation of infrahisal second-degree AV block induced by atrial pacing in the presence of chronic bundle branch block and syncope. PACE Pacing Clin Electrophysiol 19:679-687
79. Click R, Gersh B, Sugrue D et al (1987) Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol 59:817-823
80. Englund A, Bergfeldt L, Rehnqvist N, Ström H, Rosenqvist M (1995) Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope. J Am Coll Cardiol 26:1508-1515
81. Link M, Kim KM, Homoud M, Estes III M, Wang P (1999) Long-term outcome of patients with syncope associated with coronary artery disease and a non diagnostic electrophysiological evaluation. Am J Cardiol 83:1334-1337
82. Morady F, Higgins J, Peters R et al (1984) Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol 54:587-591
83. Brignole M, Menozzi C, Myoa A, Garcia-Civera R, Mont L, Alvarez M, Errazquin F, Beiras J, Bottoni N, Donateo P on behalf of the International Study on Syncope of Uncertain Etiology (ISSUE) Investigators (2001) Mechanism of Syncope in patients with bundle branch block and negative electrophysiological test. Circulation 104:2045-2050
84. Linzer M, Yang E, Estes M, Wang P, Vorperian V, Kapoor W (1997) Diagnosing syncope. Part II: Unexplained syncope. Ann Intern Med 127:76-87
85. Olshansky B, Hahn EA, Hartz VL, Prater SP, Mason JW (1999) Clinical significance of syncope in the electrophysiologic study and versus electrocardiographic monitoring (ESVEM) trial. Am Heart J 137:878-886
86. Knight B, Goyal R, Pelosi F et al (1999) Outcome of patients with non-ischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 33:1964-1970
87. Moss AJ, Hall WJ, Connom D, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (26):1933-1940
88. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341(25):1882-1890
89. Alings M, Wilde A (1999) 'Brugada' syndrome. Clincal data and suggested pathophysiological mechanism. Circulation 99:666-673
90. Brugada J, Brugada P, Brugada R (1999) The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death - the Brugada syndrome. Europace 1:156-166
91. Wichter T, Borggrefe M, Breithardt G (1998) Arrhythmogenic right ventricular cardiomyopathy. Etiology, diagnosis and therapy. Med Klin 93:(4)268-277
92. Priori SG, Bloise R, Crotti L (2001) The long QT syndrome. Europace 1:16-27
93. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparin M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Eur Heart Journal 106:69-74
94. Flammang D, Church T, Waynberger M, Chassing A, Antiel M (1997) Can adenosine 5′ triphosphate be used to select treatment in severe vasovagal syndrome? Circulation 96:1201-1208
95. Brignole M, Gaggioli G, Menozzi C et al (1997) Adenosine-induced atrioventricular block in patients with unexplained syncope. The diagnostic value of ATP test. Circulation 96:3921-3927
96. Breithardt G, Cain ME, El-Sherif N et al (1991) Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology. Eur Heart J 12:473-480
97. Byrne JM, Marais HJ, Cheek GA (1994) Exercise-induced complete heart in a patient with chronic bifascicular block. J Electrocardiol 27:339-342
98. Ascheim DD, Markowitz SM, Lai H, Engelsten ED, Stein KM, Lerman BB (1997) Vasodepressor syncope due to subclinical myocardial ischemia. J Cardiovasc Electrophysiol 8:215-221
99. Havranek EP, Dunbar DN (1992) Exertional syncope caused by left main coronary artery spasm. Am Heart J 123:792-794
100. Watanabe K, Inomata T, Miyakita Y et al (1993) Electrophysiologic study and ergonovine provocation of coronary spasm in unexplained syncope. Jpn Heart J 34:171-182
101. Rolf S, Bruns HJ, Wichter T, Kirchhof P, Ribbing M, Wasmer K, Paul M, Breithardt G, Haverkamp W, Eckardt L (2003) The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J 24:1104-1112
102. Khurana R, Lynch J, Craig F (1997) A novel psychological treatment for vasovagal syncope. Clin Aut Res 7:191-197
103. Van Dijk N, Velzeboer S, Destree-Vonk A, Linzer M, Wieling W (2001) Psychological treatment of malignant vasovagal syncope due to bloodphobia. PACE 24:122-124
104. Gaggioli G, Bottoni N, Mureddu R et al (1997) Effects of chronic vasodilator therapy to enhance susceptibility to vasovagal syncope during upright tilt testing. Am J Cardiol 80:1092-1094
105. Younoszai AK, Franklin WH, Chan DP, Cassidy SC, Allen HD (1998) Oral fluid therapy. A promising treatment for vasodepressor syncope. Arch of Pediatr and Adolescent Med 152:165-168
106. El-Sayed H, Hainsworth R (1996) Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75:114-115
107. Mtinangi BL, Hainsworth R (1998) Early effects of oral salt on plasma volume, orthostatic tolerance, and baroreceptor sensitivity in patients with syncope. Clin Autonom Res 8:231-235
108. Mtinangi B, Hainsworth R (1998) Increased orthostatic tolerance following moderate exercise training in patients with unexplained syncope. Heart 80:596-600
109. Ector H, Reybrouck T, Heidbuchel H, Gewillig M, Van de Werf F (1998) Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. PACE 21:193-196
110. Di Girolamo E, Di Iorio C, Leonzio L, Sabatini P, Barsotti A (1999) Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents. A controlled study. Circulation 100:1798-1801
111. Ward CR, Gray JC, Gilroy JJ, Kenny RA (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45-49
112. Di Gerolamo E, Di Iorio C, Sabatini O, Leonzio L, Barbone C, Barsotti A (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33:1227-1230
113. Tonnesen G, Haft J, Fulton J, Rubenstein D (1994) The value of tilt testing with isoproterenol in determining therapy in adults with syncope and presyncope of unexplained origin. Arch Intern Med 154:1613-1617
114. Mahanonda N, Bhuripanyo K, Kangkagate C et al (1995) Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 130:1250-1253
115. Jhamb DK, Singh B, Sharda B et al (1996) Comparative study of the efficacy of metoprolol and verapramil in patients with syncope and positive head-up tilt test response. Am Heart J 132:608-611
116. Biffi M, Boriani G, Sabbatini P et al (1997) Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart 77:268-272
117. Cohen MB, Snow JS, Grasso V et al (1995) Efficacy of pindolol for treatment of vasovagal syncope. Am Heart J 130:786-790
118. Iskos D, Button J, Scheinman MM, Lurie KG (1998) Usefulness of pindolol in neurocardiogenic syncope. Am J Cardiol 82:1121-1124
119. Muller G, Deal B, Strasburger JF, Benson DW Jr (1993) Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol 71:592-595
120. Ventura R, Maas R, Zeidler D, Schoder V, Nienaber CA, Schuchert A, Meinertz T (2002) A randomised and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. PACE 25:816-821
121. Brignole M, Croci F, Menozzi C, Solano A, Donateo P, Oddone D, Puggioni E, Lolli G (2002) Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 40(11):2053-2059
122. Krediet CT, van Dijk N, Linzer M, van Lieshout JJ, Wieling W (2002) Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 106 (13):1684-1689
123. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M; VPS II Investigators (2003) Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 289:2224-2229
124. Lemke B, Fischer W, Schulten HK (1996) Richtlinien zur Herzschrittmachertherapie. Indikationen, Systemwahl, Nachsorge. "Kommission für Klinische Kardiologie" der Deutschen Gesellschaft für Kardiologie - Herz-und Kreislaufforschung, Arbeitsgruppen " Herzschrittmacher" und "Arrhythmie". Z Kardiol 85:611-627
125. Hohnloser SH, Andresen D, Block M, Breithardt G, Jung W, Klein H, Kuck KH, Lüderitz B, Steinbeck G (2000) Leitlinien zur Implantation von Defibrillatoren. Z Kardiol 89:126-135
126. Driving and heart disease (1998) Task Force Report. Prepared on behalf of the Task Force by MC Fetch. Eur Heart J 19:1165-1177
127. Epstein AE, Miles WM, Benditt DG, Camm AJ et al (1996) Personal and republic safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. Circulation 94:1147-1166
128. Lewerenz H (2000) Begutachtungs-Leitlinien zur Kraftfahrereignung. Berichte der Bundesanstalt für Straßenwesen Heft M 115